In addition to heart failure, C-Pulse may turn out to be effective for patients with angina (stable angina, I believe). That potentially increases the patient population for C-Pulse by another several million in the United States alone.
Just an aside... I'm worried about the recent patient deaths. Even if they're not device related, 4 out of the first 20 seems like an unusually high mortality rate - even in a very sick population - considering that the trial has only been going for a fairly short period. We really need detailed information about this situation.
I personally think it's going to be fine, but Sunshine Heart got some splainin' to do.
SHC Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
